Dihydroartemisinin (also known as dihydroqinghaosu, artenimol or DHA) is a drug used to treat malaria. Dihydroartemisinin is the active metabolite of all artemisinin compounds (artemisinin, artesunate, artemether, etc.) and is also available as a drug in itself.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Dihydroartemisinin industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Pharmaceutical Grade
Industrial Grade
Market Segment by Product Application
Malaria Treatment
Scientific Research
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Dihydroartemisinin consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Dihydroartemisinin market by identifying its various subsegments.
3.Focuses on the key global Dihydroartemisinin manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Dihydroartemisinin with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Dihydroartemisinin submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Dihydroartemisinin Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Dihydroartemisinin Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Dihydroartemisinin Segment by Type
2.1.1 Pharmaceutical Grade
2.1.2 Industrial Grade
2.2 Market Analysis by Application
2.2.1 Malaria Treatment
2.2.2 Scientific Research
2.2.3 Others
2.3 Global Dihydroartemisinin Market Comparison by Regions (2017-2027)
2.3.1 Global Dihydroartemisinin Market Size (2017-2027)
2.3.2 North America Dihydroartemisinin Status and Prospect (2017-2027)
2.3.3 Europe Dihydroartemisinin Status and Prospect (2017-2027)
2.3.4 China Dihydroartemisinin Status and Prospect (2017-2027)
2.3.5 Japan Dihydroartemisinin Status and Prospect (2017-2027)
2.3.6 Southeast Asia Dihydroartemisinin Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Dihydroartemisinin Industry Impact
2.5.1 Dihydroartemisinin Business Impact Assessment - Covid-19
2.5.2 Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Dihydroartemisinin Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Dihydroartemisinin Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Dihydroartemisinin Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Dihydroartemisinin Manufacturer Market Share
3.5 Top 10 Dihydroartemisinin Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Dihydroartemisinin Market
3.7 Key Manufacturers Dihydroartemisinin Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Dihydroartemisinin Industry Key Manufacturers
4.1 Sanofi
4.1.1 Compan Detail
4.1.2 Sanofi Dihydroartemisinin Product Introduction, Application and Specification
4.1.3 Sanofi 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Sanofi News
4.2 KPC Pharmaceuticals
4.2.1 Compan Detail
4.2.2 KPC Pharmaceuticals Dihydroartemisinin Product Introduction, Application and Specification
4.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Sanofi News
4.3 Guangxi Xiancaotang Pharmaceutical
4.3.1 Compan Detail
4.3.2 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Introduction, Application and Specification
4.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Guangxi Xiancaotang Pharmaceutical News
4.4 Guilin Pharmaceutical
4.4.1 Compan Detail
4.4.2 Guilin Pharmaceutical Dihydroartemisinin Product Introduction, Application and Specification
4.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Guilin Pharmaceutical News
4.5 Kerui Nanhai Pharmaceutical
4.5.1 Compan Detail
4.5.2 Guilin Pharmaceutical Dihydroartemisinin Product Introduction, Application and Specification
4.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Kerui Nanhai Pharmaceutical News
4.6 Shanghai Natural Bio-engineering Co
4.6.1 Compan Detail
4.6.2 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Introduction, Application and Specification
4.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Shanghai Natural Bio-engineering Co News
4.7 Novanat Bioresource
4.7.1 Compan Detail
4.7.2 Novanat Bioresource Dihydroartemisinin Product Introduction, Application and Specification
4.7.3 Novanat Bioresource Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Botanical Extracts EPZ Ltd
4.8.1 Compan Detail
4.8.2 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Introduction, Application and Specification
4.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Botanical Extracts EPZ Ltd News
5 Global Dihydroartemisinin Market Segment by Big Type
5.1 Global Dihydroartemisinin Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Dihydroartemisinin Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Dihydroartemisinin Revenue and Market Share by Big Type (2017-2022)
5.2 Pharmaceutical Grade Sales Growth Rate and Price
5.2.1 Global Pharmaceutical Grade Sales Growth Rate (2017-2022)
5.2.2 Global Pharmaceutical Grade Price (2017-2022)
5.3 Industrial Grade Sales Growth Rate and Price
5.3.1 Global Industrial Grade Sales Growth Rate (2017-2022)
5.3.2 Global Industrial Grade Price (2017-2022)
6 Global Dihydroartemisinin Market Segment by Big Application
6.1 Global Dihydroartemisinin Sales Market Share by Big Application (2017-2022)
6.2 Malaria Treatment Sales Growth Rate (2017-2022)
6.3 Scientific Research Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Dihydroartemisinin Forecast
7.1 Global Dihydroartemisinin Revenue, Sales and Growth Rate (2022-2027)
7.2 Dihydroartemisinin Market Forecast by Regions (2022-2027)
7.2.1 North America Dihydroartemisinin Market Forecast (2022-2027)
7.2.2 Europe Dihydroartemisinin Market Forecast (2022-2027)
7.2.3 China Dihydroartemisinin Market Forecast (2022-2027)
7.2.4 Japan Dihydroartemisinin Market Forecast (2022-2027)
7.2.5 Southeast Asia Dihydroartemisinin Market Forecast (2022-2027)
7.2.6 Other Regions Dihydroartemisinin Market Forecast (2022-2027)
7.3 Dihydroartemisinin Market Forecast by Type (2022-2027)
7.3.1 Global Dihydroartemisinin Sales Forecast by Type (2022-2027)
7.3.2 Global Dihydroartemisinin Market Share Forecast by Type (2022-2027)
7.4 Dihydroartemisinin Market Forecast by Application (2022-2027)
7.4.1 Global Dihydroartemisinin Sales Forecast by Application (2022-2027)
7.4.2 Global Dihydroartemisinin Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Dihydroartemisinin Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Dihydroartemisinin Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Dihydroartemisinin
Figure Market Concentration Ratio and Market Maturity Analysis of Dihydroartemisinin
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Dihydroartemisinin Market Size by Big Type
Figure Global Market Share of Dihydroartemisinin by Big Type in 2021
Figure Pharmaceutical Grade Picture (2017-2022)
Global Dihydroartemisinin Market Size by Big Application
Table Global Dihydroartemisinin Market Size by Application
Figure Global Dihydroartemisinin Market Share by Big Application in 2021
Figure Malaria Treatment Picture
Figure Scientific Research Picture
Figure Others Picture
Table Global Dihydroartemisinin Comparison by Regions (M USD) (2017-2027)
Figure Global Dihydroartemisinin Market Size (Million US$) (2017-2027)
Figure North America Dihydroartemisinin Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Dihydroartemisinin Revenue (Million US$) Growth Rate (2017-2027)
Figure China Dihydroartemisinin Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Dihydroartemisinin Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Dihydroartemisinin Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Dihydroartemisinin Sales by Manufacturer (2017-2022)
Figure Global Dihydroartemisinin Sales Market Share by Manufacturer in 2021
Table Global Dihydroartemisinin Revenue by Manufacturer (2017-2022)
Figure Global Dihydroartemisinin Revenue Market Share by Manufacturer in 2021
Table Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Dihydroartemisinin Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Dihydroartemisinin Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Dihydroartemisinin Market
Table Key Manufacturers Dihydroartemisinin Product Type
Table Mergers & Acquisitions Planning
Table Sanofi Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Sanofi
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table KPC Pharmaceuticals Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of KPC Pharmaceuticals
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table KPC Pharmaceuticals Recent Development
Table Guangxi Xiancaotang Pharmaceutical Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Guangxi Xiancaotang Pharmaceutical
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Guangxi Xiancaotang Pharmaceutical Main Business
Table Guangxi Xiancaotang Pharmaceutical Recent Development
Table Guilin Pharmaceutical Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Guilin Pharmaceutical
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Guilin Pharmaceutical Main Business
Table Guilin Pharmaceutical Recent Development
Table Guilin Pharmaceutical Main Business
Table Guilin Pharmaceutical Recent Development
Table Kerui Nanhai Pharmaceutical Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Kerui Nanhai Pharmaceutical
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kerui Nanhai Pharmaceutical Main Business
Table Kerui Nanhai Pharmaceutical Recent Development
Table Shanghai Natural Bio-engineering Co Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Shanghai Natural Bio-engineering Co
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai Natural Bio-engineering Co Main Business
Table Shanghai Natural Bio-engineering Co Recent Development
Table Novanat Bioresource Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Novanat Bioresource
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novanat Bioresource Main Business
Table Novanat Bioresource Recent Development
Table Botanical Extracts EPZ Ltd Company Profile
Table Dihydroartemisinin Product Introduction, Application and Specification of Botanical Extracts EPZ Ltd
Table Dihydroartemisinin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Botanical Extracts EPZ Ltd Main Business
Table Botanical Extracts EPZ Ltd Recent Development
Figure Global Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure Global Dihydroartemisinin Revenue and Growth Rate (2017-2022)
Table Global Dihydroartemisinin Sales by Regions (2017-2022)
Figure Global Dihydroartemisinin Sales Market Share by Regions in 2021
Table Global Dihydroartemisinin Revenue by Regions (2017-2022)
Figure Global Dihydroartemisinin Revenue Market Share by Regions in 2021
Figure North America Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure Europe Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure China Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure Japan Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure Southeast Asia Dihydroartemisinin Sales and Growth Rate (2017-2022)
Figure Other Regions Dihydroartemisinin Sales and Growth Rate (2017-2022)
Table Global Dihydroartemisinin Sales by Big Type (2017-2022)
Table Global Dihydroartemisinin Sales Market Share by Big Type (2017-2022)
Figure Global Dihydroartemisinin Sales Market Share by Big Type in 2019
Table Global Dihydroartemisinin Revenue by Big Type (2017-2022)
Table Global Dihydroartemisinin Revenue Market Share by Big Type (2017-2022)
Table Global Dihydroartemisinin Revenue Market Share by Big Type in 2019
Figure Global Pharmaceutical Grade Sales Growth Rate (2017-2022)
Figure Global Pharmaceutical Grade Price (2017-2022)
Figure Global Industrial Grade Sales Growth Rate (2017-2022)
Table Global Dihydroartemisinin Sales by Big Application (2017-2022)
Table Global Dihydroartemisinin Sales Market Share by Big Application (2017-2022)
Figure Global Dihydroartemisinin Sales Market Share by Big Application in 2019
Figure Global Malaria Treatment Sales Growth Rate (2017-2022)
Figure Global Scientific Research Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Dihydroartemisinin Sales and Growth Rate (2022-2027)
Figure Global Dihydroartemisinin Revenue and Growth Rate (2022-2027)
Table Global Dihydroartemisinin Sales Forecast by Regions (2022-2027)
Table Global Dihydroartemisinin Market Share Forecast by Regions (2022-2027)
Figure North America Sales Dihydroartemisinin Market Forecast (2022-2027)
Figure Europe Sales Dihydroartemisinin Market Forecast (2022-2027)
Figure China Sales Dihydroartemisinin Market Forecast (2022-2027)
Figure Japan Sales Dihydroartemisinin Market Forecast (2022-2027)
Figure Southeast Asia Sales Dihydroartemisinin Market Forecast (2022-2027)
Figure Other Regions Sales Dihydroartemisinin Market Forecast (2022-2027)
Table Global Dihydroartemisinin Sales Forecast by Type (2022-2027)
Table Global Dihydroartemisinin Market Share Forecast by Type (2022-2027)
Table Global Dihydroartemisinin Sales Forecast by Application (2022-2027)
Table Global Dihydroartemisinin Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dihydroartemisinin
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Dihydroartemisinin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Dihydroartemisinin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Dihydroartemisinin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Dihydroartemisinin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Dihydroartemisinin Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Dihydroartemisinin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Dihydroartemisinin Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Dihydroartemisinin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)